Haemonetics Corporation
- HAE
- NYSE
- Medical devices
- Plasma Collection Systems
- Blood Management Devices
$118.73
Today +0.38%Quote Oct 19, 2026, 08:00 PM UTC
+9.53%over the last month
Max drawdown −6.5%From 1-month high −2.7%3 months +52.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Haemonetics
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions.
Sector
Healthcare
Industry
Medical devices
Exchange
NYSE
Employees
3,009
Market value
$5.40B
Quote Oct 19
Floor
$116.39
2.0% below price
Resistance
$120.08
1.1% above price
Price vs analyst targets
21 analysts
Lowest target
$119.00Highest target
$140.00
$119.00Highest target
$140.00
- Price $118.73
- Average target $130.80
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 10% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about HAEPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free